Aemetis Inc
$ 1.52
0.66%
11 Feb - close price
- Market Cap 99,962,000 USD
- Current Price $ 1.52
- High / Low $ 1.55 / 1.47
- Stock P/E N/A
- Book Value -4.69
- EPS -1.50
- Next Earning Report 2026-03-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.13 %
- ROE N/A %
- 52 Week High 3.66
- 52 Week Low 1.22
About
Aemetis, Inc. is a biochemical and renewable natural gas and fuels company in North America and India. The company is headquartered in Cupertino, California.
Analyst Target Price
$13.38
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-03-05 | 2024-11-07 | 2024-08-01 | 2024-05-09 | 2024-03-07 | 2023-11-09 | 2023-08-03 | 2023-05-04 | 2023-03-09 |
| Reported EPS | -0.37 | -0.41 | -0.47 | -0.3544 | -0.3799 | -0.66 | -0.58 | -0.64 | 0.73 | -0.68 | -0.73 | -0.63 |
| Estimated EPS | -0.19 | -0.28 | -0.45 | -0.4052 | -0.42 | -0.43 | -0.46 | -0.34 | -0.29 | -0.39 | -0.39 | -0.27 |
| Surprise | -0.18 | -0.13 | -0.02 | 0.0508 | 0.0401 | -0.23 | -0.12 | -0.3 | 1.02 | -0.29 | -0.34 | -0.36 |
| Surprise Percentage | -94.7368% | -46.4286% | -4.4444% | 12.537% | 9.5476% | -53.4884% | -26.087% | -88.2353% | 351.7241% | -74.359% | -87.1795% | -133.3333% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-12 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.28 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMTX
2026-02-07 21:57:26
Aemetis Biogas LLC, a subsidiary of Aemetis, Inc., has extended the deadline for redeeming Series A Preferred Units to April 30, 2026, from the previous December 31, 2025 date. This comes as the company faces significant financial distress with a substantial debt burden and a "WEAK" financial health rating according to InvestingPro. If redemption is not completed, Aemetis Biogas will enter a credit agreement with Protair-X Technologies and Third Eye Capital, involving a high-interest loan and asset guarantees from Aemetis, Inc. and its subsidiaries.
2026-02-07 09:01:29
Aemetis, through its subsidiary Aemetis Biogas, has amended its Series A Preferred Unit Purchase Agreement with Protair-X Technologies and Third Eye Capital. This amendment extends the redemption deadline for all outstanding Series A Preferred Units to April 30, 2026, setting the aggregate redemption price at $114.7 million, which includes a $2 million amendment fee. Should the units not be redeemed by this new date, Aemetis Biogas will enter into a new credit agreement, effective May 1, 2026, with a maturity of May 1, 2027, bearing an interest rate of 16.0% or prime plus 10.0%, whichever is greater.
2026-02-07 08:29:47
Aemetis Biogas LLC, a subsidiary of Aemetis, Inc., has extended the deadline to redeem its Series A Preferred Units to April 30, 2026, from the previous December 31, 2025. This extension addresses the company's significant debt burden and potential financial distress, as evidenced by a "WEAK" financial health rating and a deeply negative Altman Z-Score. If redemption is not completed, a credit agreement with Protair-X Technologies Inc. and Third Eye Capital Corporation will be enacted, involving high-interest loans guaranteed by Aemetis and its subsidiaries.
2026-02-07 00:01:29
Aemetis Biogas LLC, a subsidiary of Aemetis, Inc., has extended the redemption deadline for its Series A Preferred Units to April 30, 2026, due to significant debt and weak financial health. If the redemption is not completed, the subsidiary will enter into a credit agreement with Protair-X Technologies Inc. and Third Eye Capital Corporation with specific interest rates and guarantee requirements. The redemption amount of $114.7 million exceeds the company's current market capitalization, highlighting the financial challenges.
2026-02-03 12:58:50
Aemetis's India subsidiary, Universal Biofuels, has secured a $24 million allocation to supply over 27 million liters of biodiesel to India's government-owned OMCs through March 2026. The company has expanded its Kakinada plant to 80 million gallons per year and uses a proprietary enzymatic process. Additionally, Universal Biofuels is preparing for an IPO of a minority stake to support its growth initiatives.
2026-02-03 12:58:50
Aemetis, Inc.'s Universal Biofuels subsidiary in India has secured allocations worth approximately $24 million to supply over 27 million liters of biodiesel to India's government-owned Oil Marketing Companies (OMCs) through March 2026. This move supports India's National Policy on Biofuels target of increasing biodiesel blending to 5%, up from the current less-than-1% level. Universal Biofuels, a major Indian biodiesel producer, has expanded its Kakinada plant capacity to 80 million gallons per year and plans an IPO for diversification and growth.
